GlassScriptPhysician profile
Jeffrey Allen Muldoon
NPI 1720460629
$6,634.10
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $141 · 2021: $2,896 · 2022: $1,227 · 2023: $2,243 · 2024: $128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,940 · Food and Beverage: $431.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,939.78 |
| Food and Beverage | $430.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medwest Associates | $5,401.17 | 2021-2023 | |
| Arthrex, INC. | $462.48 | 2023 | |
| Paragon 28, INC. | $355.35 | 2019-2024 | Hammertube, Precision Mis Bunion, Grappler |
| Misonix INC | $115.60 | 2021 | |
| Integra Lifesciences Corporation | $101.94 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Smith+Nephew, INC. | $80.70 | 2021 | |
| Stryker Corporation | $75.42 | 2019-2022 | |
| Acera Surgical, INC. | $15.62 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $14.45 | 2022 | |
| Kerecis Limited | $11.37 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Muldoon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.